Symbols

SKIN

The Beauty Health·NASDAQ

--(--)

SKIN fundamentals

SKIN Q4 2025 Earnings

The Beauty Health (SKIN) released its earnings on Mar 12, 2026: revenue was 82.40M (YoY -1.32%), beat estimates; EPS was -0.06 (YoY +25.00%), missed estimates.

Revenue / YoY

82.40M

-1.32%

EPS / YoY

-0.06

+25.00%

Report date

Mar 12, 2026

SKIN Earnings Call Summary for Q4,2025

Resilient Q4 Results: Adjusted EBITDA up 67% to $15M, driven by margin expansion. Consumables growth (+1.7%) outperformed devices.
2026 Strategy: Focus on installed base utilization and innovation, with 2027 growth outlook. Q1 2026 revenue expected at $63-68M.
Innovation Pipeline: Next-gen Hydrafacial device set for 2028 launch, targeting installed base upgrades.
Market Trends: Non-invasive treatments hold steady, with Gen Z and men driving new consumer segments.
Financial Discipline: 2026 EBITDA guidance ($35-45M) reflects reinvestment in R&D for long-term growth.

Earnings

EPS

Revenue

Revenue & Expenses

SKIN has released its 2025 Q4 earnings report, with revenue of 82.37M, reflecting a YoY change of -1.35%, and net profit of -8.10M, showing a YoY change of 21.55%. The Sankey diagram below clearly presents SKIN's revenue sources and cost distribution.

Key Indicators

The Beauty Health (SKIN) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

The Beauty Health (SKIN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

The Beauty Health (SKIN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

The Beauty Health (SKIN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown